Clinical Catch-Up: January 18-22 | BioSpace
The Pharma Data
JANUARY 24, 2021
Gritstone Oncology , based in Emeryville, California, announced that it is advancing development of its own second-generation vaccine against COVID-19. Quantum Genomics launched its Phase III REFRESH trial in difficult-to-treat or resistant hypertension. Read on to see. COVID-19-Related. BT-001 is based on the patented Invir.IO
52 
Let's personalize your content